| Issue |
Section |
Title |
File |
| No 17 (2014) |
Articles |
Molekulyarno-geneticheskaya geterogennost' melanomy kozhi i ee znachenie dlya razrabotki individual'nykh podkhodov k lecheniyu |
|
| No 17 (2014) |
Articles |
Novye preparaty, vosstanavlivayushchie immunnyy kontrol' nad opukhol'yu v terapii patsientov s metastaticheskoy melanomoy |
|
| No 18 (2015) |
Articles |
Lechenie zlokachestvennykh novoobrazovaniy s mutatsiey gena BRAF V600 s ispol'zovaniem vemurafeniba |
|
| No 8 (2017) |
Articles |
Experience of the use of combination of dabrafenib and trametinib in patients with metastatic skin melanoma in real clinical practice in Russia |
|
| No 8 (2017) |
Articles |
Domestic antitumor preparation Aranose in the treatment of patients with metastatic skin melanoma -results of a prospective randomized study |
|
| No 8 (2017) |
Articles |
Combined targeted therapy with dabraphenib +trametinib in treatment of melanoma patients with V600 BRAF mutations and brain metastases |
|
| No 17 (2017) |
Articles |
Opportunities of combined targeted therapy with vemurafenib and cobi-metinib in metastatic BRAF-positive cutaneous melanoma: long-term results of clinical trials |
|
| No 12 (2018) |
Articles |
Tumors hyperprogression phenomenon against the background of the use of PD1 blocators: myths or reality? |
|
